ARDP0006
| Code | Size | Price |
|---|
| TAR-T19900-500mg | 500mg | £111.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
ARDP0006 is an inhibitor of NS2B-NS3 protease.
CAS:
81-55-0
Formula:
C14H6N2O8
Molecular Weight:
330.208
Purity:
0.9723
SMILES:
Oc1ccc(c2C(=O)c3c(ccc(O)c3C(=O)c12)[N+]([O-])=O)[N+]([O-])=O
References
1. Justin Jang Hann Chu, Regina Ching Hua Lee, Melgious Jin Yan Ang,et al.Antiviral activities of 15 dengue NS2B-NS3 protease inhibitors using a human cell-based viral quantification assay.Antiviral Res. 2015 Jun;118:68-74. doi: 10.1016/j.antiviral.2015.03.010. Epub 2015 Mar 27.
2. Constant D A , Mateo R , Nagamine C M , et al. Targeting intramolecular proteinase NS2B/3 cleavages for trans -dominant inhibition of dengue virus[J]. Proceedings of the National Academy of Sciences, 2018, 115(40):201805195.